Crossmark

Pharmacovigilance analysis of metabolic and nutritional adverse reactions associated with entecavir and tenofovir using the FDA adverse event reporting system database

Crossref DOI link: https://doi.org/10.1007/s11096-025-01969-1

Published Online: 2025-08-19

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhu, Haomin

Ding, Baolong

Jing, Zhuying

Yao, Hongting

Li, Yue

Gao, Lihong

Zhu, Yulu

Li, Xin https://orcid.org/0000-0003-3951-8061
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (72074123)
License Information

Text and Data Mining valid from 2025-08-19

Version of Record valid from 2025-08-19
More Information

Article History

Received: 6 May 2025

Accepted: 26 June 2025

First Online: 19 August 2025

Declarations

:

: The authors declare no competing interests.

: Because FAERS is a publicly available and anonymized database, this study did not require ethical approval.

Document is current

Any future updates will be listed below